UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047815
Receipt number R000054510
Scientific Title Effectiveness of anma massage therapy for lymphedema in survivors of gynecologic cancer
Date of disclosure of the study information 2022/05/20
Last modified on 2022/11/23 14:11:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of anma massage therapy for lymphedema in survivors of gynecologic cancer

Acronym

Anma massage for lymphedema in survivors of gynecologic cancer

Scientific Title

Effectiveness of anma massage therapy for lymphedema in survivors of gynecologic cancer

Scientific Title:Acronym

Anma massage for lymphedema in survivors of gynecologic cancer

Region

Japan


Condition

Condition

lymphedema

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to explore the effectiveness of anma massage therapy for postoperative lymphedema in survivors of gynecologic cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Lower limb circumference (five circumference measurements: from the head of the first metatarsal to head of the fifth metatarsal; at the ankle, from the lateral to medial malleolus; 5 cm below head of the fibula; 10 cm above the top of the patella; and at the thigh, at the point of the greater trochanter)
We measure before and after the intervention/control duration, and also measure before and after each session.

Key secondary outcomes

1) Quality of life, measured using a self-administered questionnaire, the Japanese version of Quality of Life Measurement for Limb Lymphedema (J-LYMQOL).
2) Blood flow velocity in the great saphenous vein, measured using a bidirectional vascular Doppler.
We measure before and after the intervention/control duration.


Base

Study type

Interventional


Study design

Basic design

n-of-1

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Anma massage therapy + usual care for lymphedema (wearing an elastic stocking): A 60-min whole-body anma massage session administered once a week for 6 weeks (6 sessions in total). Sessions are followed by our anma massage protocol modified specifically for lymphedema.

Interventions/Control_2

Usual care for lymphedema (wearing an elastic stocking) for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Diagnosis of gynecologic cancer and completion of standard medical treatment, with subsequent development of lymphedema

Key exclusion criteria

1) Not completed standard medical treatment or currently undergoing chemotherapy or radiotherapy.
2) Inflammatory disorder of the lower limb, such as cellulitis, lymphangitis, and acute dermatitis
3) Deep vein thrombosis
4) Serious cardiac disease
5) Other disease that contraindicates anma massage therapy, such as severe dementia, severe kidney disease, and inflammatory disorder in other organs
6) Deemed ineligible to participate this study by a medical doctor (Research Collaborator)

Target sample size

1


Research contact person

Name of lead principal investigator

1st name Nozomi
Middle name
Last name DONOYAMA

Organization

Tsukuba University of Technology

Division name

Department of Health, Faculty of Health Sciences

Zip code

305-8521

Address

4-12-7 Kasuga, Tsukuba, Ibaraki 305-8521, Japan.

TEL

+81-29-858-9631

Email

donoyama@k.tsukuba-tech.ac.jp


Public contact

Name of contact person

1st name Nozomi
Middle name
Last name DONOYAMA

Organization

Tsukuba University of Technology

Division name

Department of Health, Faculty of Health Sciences

Zip code

305-8521

Address

4-12-7 Kasuga, Tsukuba, Ibaraki 305-8521, Japan.

TEL

+81-29-858-9631

Homepage URL


Email

donoyama@k.tsukuba-tech.ac.jp


Sponsor or person

Institute

MEXT(Japan)

Institute

Department

Personal name



Funding Source

Organization

MEXT(Japan)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

University of Tsukuba

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Ethics Commitee, Tsukuba University of Technology

Address

4-12-7 Kasuga, Tsukuba, Ibaraki 305-8521, Japan.

Tel

+81-29-858-9596

Email

iji@ad.tsukuba-tech.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波技術大学(茨城県)


Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 04 Month 18 Day

Date of IRB

2022 Year 04 Month 27 Day

Anticipated trial start date

2022 Year 06 Month 01 Day

Last follow-up date

2022 Year 12 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Due to upset for participants' recruitment, the registration of modification of the study design was submitted, and approved by the Medical Ethics Commitee, Tsukuba University of Technology on 27 July, 2022.


Management information

Registered date

2022 Year 05 Month 20 Day

Last modified on

2022 Year 11 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054510


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name